# Genetic Architecture of Myopia and Its Implications for Risk Stratification and Prognosis

**Authors:** Yuri Seo, Dongheon Surl, Jinu Han

PMC · DOI: 10.3390/diagnostics16040536 · 2026-02-11

## TL;DR

This paper explores the genetic basis of myopia and how it can help predict and manage the condition more effectively.

## Contribution

The paper presents a multilayered genetic framework for myopia, integrating polygenic and rare variant analyses for risk stratification.

## Key findings

- Myopia-related genetic variants are enriched in pathways affecting retinal responses to visual and metabolic stimuli.
- Polygenic risk scores can quantify genetic susceptibility for population-level risk assessment.
- Early-onset high myopia overlaps with inherited retinal and syndromic disorders.

## Abstract

Myopia is a prevalent ocular condition with marked heterogeneity in onset and progression. Although diagnosis is straightforward, predicting disease trajectories and identifying risks of high or pathologic myopia remain main clinical challenges. Advances in human genetics have substantially reshaped current understanding of myopia, revealing a complex architecture involving common polygenic susceptibility, rare high-impact variants, and cumulative genetic risk burden. Large-scale genome-wide association studies demonstrate that myopia-related variants are enriched in regulatory and signaling pathways that modulate retinal neuronal and glial responses to visual and metabolic stimuli, while exome sequencing studies highlight overlap between early-onset high myopia and inherited retinal or syndromic disorders. Polygenic risk scores further translate common-variant burden into quantitative measures of genetic susceptibility, enabling population-level risk stratification and early risk assessment, albeit with performance differences across ancestries and clinical outcomes. Together, these findings delineate a multilayered genetic framework for myopia and support the role of genetic information as a complementary component of prognostic assessment. Integration of genetic data with longitudinal clinical and environmental information may further improve the prediction of myopia trajectories and facilitate more individualized management strategies.

## Linked entities

- **Diseases:** myopia (MONDO:0001384)

## Full-text entities

- **Genes:** PDE6H (phosphodiesterase 6H) [NCBI Gene 5149] {aka ACHM6, RCD3}, GNB3 (G protein subunit beta 3) [NCBI Gene 2784] {aka CSNB1H, HG2D}, NYX (nyctalopin) [NCBI Gene 60506] {aka CLRP, CSNB1, CSNB1A, CSNB4, NBM1}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CHRM1 (cholinergic receptor muscarinic 1) [NCBI Gene 1128] {aka HM1, M1, M1R}, COL11A1 (collagen type XI alpha 1 chain) [NCBI Gene 1301] {aka CO11A1, COLL6, DFNA37, STL2}, KDELR3 (KDEL endoplasmic reticulum protein retention receptor 3) [NCBI Gene 11015] {aka ERD23, ERD2L3}, ZEB2 (zinc finger E-box binding homeobox 2) [NCBI Gene 9839] {aka HSPC082, SIP-1, SIP1, SMADIP1, ZFHX1B}, SLC39A5 (solute carrier family 39 member 5) [NCBI Gene 283375] {aka LZT-Hs7, MYP24, ZIP5}, TRPM1 (transient receptor potential cation channel subfamily M member 1) [NCBI Gene 4308] {aka CSNB1C, LTRPC1, MLSN1}, VIPR2 (vasoactive intestinal peptide receptor 2) [NCBI Gene 7434] {aka C16DUPq36.3, DUP7q36.3, PACAP-R-3, PACAP-R3, VIP-R-2, VPAC2}, CNGA3 (cyclic nucleotide gated channel subunit alpha 3) [NCBI Gene 1261] {aka ACHM2, CCNC1, CCNCa, CCNCalpha, CNCG3, CNG3}, CHRNB1 (cholinergic receptor nicotinic beta 1 subunit) [NCBI Gene 1140] {aka ACHRB, CHRNB, CMS1D, CMS2A, CMS2C, SCCMS}, IFT140 (intraflagellar transport 140) [NCBI Gene 9742] {aka CED5, MZSDS, PKD9, RP80, SRTD9, WDTC2}, RORB (RAR related orphan receptor B) [NCBI Gene 6096] {aka EIG15, NR1F2, ROR-BETA, RORbeta, RZR-BETA, RZRB}, AREG (amphiregulin) [NCBI Gene 374] {aka AR, AREGB, CRDGF, SDGF}, PPEF2 (protein phosphatase with EF-hand domain 2) [NCBI Gene 5470] {aka PPP7CB}, LOXL3 (lysyl oxidase like 3) [NCBI Gene 84695] {aka LOXL, MYP28}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, FGF9 (fibroblast growth factor 9) [NCBI Gene 2254] {aka FGF-9, GAF, HBFG-9, HBGF-9, SYNS3}, GLRA2 (glycine receptor alpha 2) [NCBI Gene 2742] {aka GLR, MRXSP}, GJD2 (gap junction protein delta 2) [NCBI Gene 57369] {aka CX36, GJA9}, ATF6 (activating transcription factor 6) [NCBI Gene 22926] {aka ACHM7, ATF6A, ATP6alpha}, RP1L1 (RP1 like 1) [NCBI Gene 94137] {aka DCDC4B, OCMD, RP88}, LAMA2 (laminin subunit alpha 2) [NCBI Gene 3908] {aka LAMM, MDC1A}, PDE6C (phosphodiesterase 6C) [NCBI Gene 5146] {aka ACHM5, COD4, PDEA2}, EGR1 (early growth response 1) [NCBI Gene 1958] {aka AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268}, COL2A1 (collagen type II alpha 1 chain) [NCBI Gene 1280] {aka ACG2, ANFH, ANFH1, AOM, COL11A3, EDMMD}, PSMD3 (proteasome 26S subunit, non-ATPase 3) [NCBI Gene 5709] {aka P58, RPN3, S3, TSTA2}, EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3) [NCBI Gene 9451] {aka PEK, PERK, WRS}, RGR (retinal G protein coupled receptor) [NCBI Gene 5995] {aka RP44}, CHRM2 (cholinergic receptor muscarinic 2) [NCBI Gene 1129] {aka HM2}, RASGRF1 (Ras protein specific guanine nucleotide releasing factor 1) [NCBI Gene 5923] {aka CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55}, SNTB1 (syntrophin beta 1) [NCBI Gene 6641] {aka 59-DAP, A1B, BSYN2, DAPA1B, SNT2, SNT2B1}, ARR3 (arrestin 3) [NCBI Gene 407] {aka ARRX, MYP26, cArr}, OPN1MW (opsin 1, medium wave sensitive) [NCBI Gene 2652] {aka CBBM, CBD, COD5, GCP, GOP, OPN1MW1}, ZNF644 (zinc finger protein 644) [NCBI Gene 84146] {aka BM-005, MYP21, NatF, ZEP-2}, CHRM3 (cholinergic receptor muscarinic 3) [NCBI Gene 1131] {aka EGBRS, HM3, PBS, m3AChR}, CNGB3 (cyclic nucleotide gated channel subunit beta 3) [NCBI Gene 54714] {aka ACHM1}, OPN1LW (opsin 1, long wave sensitive) [NCBI Gene 5956] {aka CBBM, CBP, COD5, RCP, ROP}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, RPGR (retinitis pigmentosa GTPase regulator) [NCBI Gene 6103] {aka COD1, CORDX1, CRD, PCDX, RP15, RP3}, DRD1 (dopamine receptor D1) [NCBI Gene 1812] {aka D1R, DADR, DRD1A}, P4HA2 (prolyl 4-hydroxylase subunit alpha 2) [NCBI Gene 8974] {aka MYP25, lncRNA-PE}, TIMP2 (TIMP metallopeptidase inhibitor 2) [NCBI Gene 7077] {aka CSC-21K, DDC8}, CACNA1F (calcium voltage-gated channel subunit alpha1 F) [NCBI Gene 778] {aka AIED, COD3, COD4, CORDX, CORDX3, CSNB2}, WNT7B (Wnt family member 7B) [NCBI Gene 7477]
- **Diseases:** chest deformities (MESH:D013898), FEVR (MESH:D000080345), AR (MESH:D013734), Achromatopsia (MESH:D003117), GS (MESH:D042822), inherited retinal dystrophies (MESH:D058499), LCA (MESH:D057130), disorder of scleral biomechanics (MESH:D015422), Polydactyly (MESH:D017689), axial elongation (MESH:C537791), elongation (MESH:C538010), IRD (MESH:D052919), Mainzer-Saldino syndrome (MESH:D012779), Refractive Error and Myopia (MESH:D012030), Knobloch syndrome (MESH:C537209), X-Linked (MESH:C536424), ES (MESH:D010855), CSNB (MESH:C536122), IRDs (MESH:D012164), glaucoma (MESH:D005901), skeletal anomalies (MESH:C535534), myopic (MESH:D001251), thinned (MESH:D013851), Myopia (MESH:D009216), myopic macular degeneration (MESH:D008268), chromosomal abnormalities (MESH:D002869), heart valvular diseases (MESH:D006349), vitreoretinopathy (MESH:D018630), Renal failure (MESH:D051437), AD (MESH:D000544), acuity (MESH:D014786), optic atrophy (MESH:D009896), lens dislocation (MESH:D007906), late-onset high myopia (MESH:D000067562), ocular condition (MESH:D020763), injury to (MESH:D014947), Syndromic Diseases (MESH:D004194), hypoxia (MESH:D000860), EOSRD (MESH:C565741), retinal detachment (MESH:D012163), hereditary retinal diseases (MESH:D030342), Sensorineural hearing loss (MESH:D006319), Stickler syndrome (MESH:C537492), mitochondrial dysregulation (MESH:D021081), Marfan syndrome (MESH:D008382), nystagmus (MESH:D009759), infantile nystagmus (MESH:C580539), obesity (MESH:D009765), skeletal abnormalities (MESH:D009139)
- **Chemicals:** GxE (-), calcium (MESH:D002118), dopamine (MESH:D004298), lactate (MESH:D019344), atropine (MESH:D001285)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** p.I178V, rs2071623, p.A174V, p.S180A, p.L153M, p.V171I
- **Cell lines:** RPE — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_IQ82)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939625/full.md

---
Source: https://tomesphere.com/paper/PMC12939625